<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 329 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page328.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=329">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 329 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 329</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=329"><img src="../thumb/329.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>292 / 2020-04                                                          Endocrine System - 19.1.2
   Drug interactions: Intrins.hyperglycaem.activ.of glucocortic./  antibact. sulphonam./fluoroquinolon/warfar./ MAOI’s/chloram-  (S3) MODIF.REL.TABS, 49/21.2/1207
   beta-2-agon.& diurets., poss. hypoglycaem. with concom.sulpho-  phenicol/fenofibrate/pentoxifyll./disopyramide/clofibrate/cyclo-  3000684-001: 30 mg, 60, R61,20
   nylurea, ACE-inhibit.poss.decr.bld.gluc.lev., reduc.clear.with cime-  phosphamide/salicylates/propranol & other ß-block., antidiuret.   Dosage: Adults: Dly.dos.30-120 mg/day as sngl. dly.dos. with
   tidine, warfar.activ.dimin.  activ. of desmopress.reduc., ac.alcoh.intoxicat. incr. lact.acidos.  breakf. Adjust.accord.to indiv. metabol. respons. Init.dos& prev.un-
   GLUCOPHAGE XR, (Biopharma Div) Merck [P/S] &  risk, glucoster./ß-block.& diuret. have intrins. hyperglycaem. activ.,   treat.pts: 30 mg once dly.with breakf.
                                                              If fast.bld.gluc.lev.not decr.satisfact.incr.dos. progress. to 60 mg,90
                                ACE-inhibit. decr. bld.gluc.
   Metformin HCl.                                             mg or 120 mg/day with 1 mnth. interv.betw.increm.except where
   Indications: Type 2 diab.mellit.in adults esp.in overweight pts.  GLYCOMIN, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  bld.gluc. has not decr.aft.15 days when an incr.poss.at end of 2 nd
   when diet managem.& exerc.alone do not result in adeq.glycaem.  Glibenclamide.  wk.of treatm. Max.dly.dos: 120 mg.
   control. May be given alone as init.ther./can be admin.in combinat.   Indications: Maturity-onset diabet.where diet alone has failed   Gliclazide replacem.ther: Prev.80 mg gliclazide = 1 tab.Glytab 30 mg.
   with other oral antidiabet.agents/insul.  and insul.cannot be used  Other sulphonylur.replacem.ther: When tfd. consid. dos.& half-
   (S3) XR TABS, A39/21.2/0027, 43/21.2/0185 45/21.2/0066  (S3) TABS. Q/21.2/24.  life of prev.oral hypoglycaem. If chang. from another oral sulphony-
   710196-001: 500 mg, 90, R63,75  729361-004: 5 mg, 30, R9,74  lur.with prolong. half-life a therapeut.window of a few days poss.
   720926-002: 1000 mg, 60, R113,36  729361-012: 5 mg, 100, R32,46  necess. to avoid addit.eff.& hypoglycaem.risk. Dur. changeover
   Dosage: XR 500 mg: The usual start.dos.is 1 tab. dly giv.with even.  729361-020: 5 mg, 500, R162,33  init.30 mg/day incr.increm.accord.to pts metabol.evolut.
   meal. Aft.10-15 days dos.should be adjust.on basis of bld.gluc.meas-  Dosage: Init.5 mg dly.with/immed.bef.breakf., adjust aft.± 7 days   Other oral antidiabet.combinat: Check control with bld.sugar
   urem. A slow dos.incr.may improve gastro-intestin.tolerabil. The max.  by 2,5 mg dly up to 15 mg dly. Dly dos.in excess of 10 mg to be   read.when combin.with alpha glucosid.inhibit./insul. Great.risk of
   recomm.dos is 4 tabs.dly. Incr.should be made in increm.of 500 mg   admin.in 2 div. dos.  CV mortal. when combin.with biguan.
   every 10-15 days up to max. 2 000 mg once dly.with even.meal. If   Contraindications: IDDM, diab.mellit.in young people, diab.  Contraindications: Other sulphonylurea/ sulphonam. hypersens.,
   glycaem. control not achiev.with 4 tabs once dly consid. 2 tabs. 2xdly   mellit.complicat.by ketoacidos/sev.infect./stress/trauma or sev.  type 1 diab., diab. ketoacidos., diab.pre-coma, childr., sev. ren./ hepat.
   admin.with food. If glycaem.control still not achiev.consid.switch.to   ren.or hepat,or thyroid funct., chron.liv.dis.caus.by uncompensat.  insuffic., pregn., lactat.
   std.metform.tabs. with max.dos of 3 000 mg dly.  card.fail./alcohol.  Side effects: Freq: Hypoglycaem.with poss.signs of adrenerg.
   XR 1 000 mg is intend.as maint.ther.for pts. already treat.with either   Side effects: Hypoglycaem., GI disturbs., tinnit., metal.taste, CNS   counter-regulat., dizzin., drowsin., taste disturbs., polyuria, head-
   1 000 mg (ie 2 tabs. XR 500 mg) or 2 000 mg (4 tabs.XR 500 mg) sus-  effs., prurit., skin rash., photosens., allerg.reacts.incl.erythema mul-  ache, incr.weight. Less freq: anaem., leucopen., thrombocytopen.,
   tain. release metform.HCl. If glycaem.control still not achiev.consid.  tiforme & exfoliat.dermatit., jaund., bld.dyscras., intol.to alcoh.incl.  pancytopen., eosinophil., angioed., sev. hypoglycaem., trans.vis.
   switch.to std.metform.tabs.to a max. dly.dos of 3 000 mg.  fac.flush., diuret.act.  disturbs., abdom.pain, N&V, dyspeps., diarrh., constipat., hepatit.,
   Switch.pts.already treat. with metform.tabs: Start.dos.of XR pro-  Special precautions: Elderly, porphyr.oss. exacerbat., substit.with   cholestas., cholestat.jaund., hepat.funct.impairm., porphyr., skin
   long.release tabs.should be equiv.to the dly.dos.of metformin immed.  insul.when maj.surg. plann., lact.intol.  rash, prurit., urticar., erythema multiforme, maculopapul.rash., pho-
   release tabs. In pts.treat.with metform at a dos.above 2 000 mg dly.  Drug interactions: Hypoglycaem.eff.enhanc.by antibiot./coumar.  tosens., Stev.John.syndr., TEN, drug rash with eosinophil.& system.
   switch.to Gluophage XR is not recomm.  anticoags./anti-inflamm./analges. incl.azapropazone & phenylb-  sympt.(DRESS) syndr.
   Contraindications: Diabet.coma & ketoacidos., diabet. pre-  utaz.& salicyl./lipid regulat.agents/cimetid./ranitid./fenfluram./  Warnings and special precautions: Assoc. incr. CV mortal.
   coma, ren.fail./dysfunct., ac.condits. with potent.to alt.ren.funct.  indobufen/methyldopa/miconazole & sulphinpyrazone, hypogly-  as compar.to diet alone/diet & insulin., malnutrit./irreg.or miss.
   eg.dehydrat/sev. infect./ shock/intravasc.admin.of iodinat.contrast   caem.eff.dimin.by adrenaline/corticoster. /thiazide diuret./rifampic   meals/condit. favour.hypoglycaem., bld. gluc.contr.poss.affect.by
   agents, ac./chron.dis.poss.caus.tiss.hypox.e.g. card./ resp.fail./rec.  & OC’s, ß-block.may mask hypoglycaem.sympts., gut absorpt.re-  fev./trauma/infect.or surg.intervent./concom.St John’s Wort when
   MI/shock, hepat.insuffic., ac. alcoh. intoxicat., alcohol., pregn.&   duc.by guar gum.  insul.admin.poss.necess., second. effic.poss.attenuat.over time due
   lactat., pancreatit.         Warning: Assoc.incr.CV mortal.  to dis progress/reduc.treatm.respons., monit.bld.gluc. with concom.
   Side effects: Decr.Vit.B12 absorpt.dur.longt. ther., GI disturbs., skin   fluoroquinolones,consid.non-sulphonylur. alternat.with G6PD defic.,
   reacts., lact.acidos., metal.taste, hepatit.  GLYCRON, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  poss. adverse effs.that may affect ability to drive/ operate machin.,
   Warnings and special precautions: Discont.& hospitalis. if me-  Gliclazide  change to insul.ther.bef. attempt.pregn.or as soon as pregn.discov.,
   tabol.acidos.suspect., reduc.incid. of lactat.acidos.by assess.assoc.  Indications: Matur.onset diabet.mellit.not contr. by diet alone.  hypoglycaem. can recur.even if init.meas.prove effect.theref.seek
   risk fact.eg.poor. controll. diab./ketosis, prolong.fast./excess.alcoh.   (S3) TABS. 31/21.2/0311.  medic.treatm., discont.in event of cholestat.jaund.
   intake/ hepat.insuffic. & other condits.assoc.with hypox., monit.ren.  838209-009: 80 mg, 60, R67,44  Interactions: Incr.hypoglycaem.risk with antifung./ barbitur./ ß-
   funct.bef.init.treatm.& reg. thereaft. esp.elderly, condits.where ren.  Dosage: Indiv. Init.40 to 80 mg dly. Incr.grad.to 320 mg dly.if necess   block./cimetidine/ ranitidine/ allopurinol/ACE inhibit., MAOI’s/
   funct.may become imp., discont.ther.bef.intravasc.admin.of iodinat.   in div.dos.morn.&even.  NSAID’s & alchol., incr.hyperglycaem.risk with glucocortic./ thiazide
   contrast agents allow.48 hr.interv & re-eval. ren.funct.bef.re-comm.  Contraindications: Sulphonylurea hypersens., IDDM, pregn.&   diuret./Li/salbutamol/IV terbutal./ other ß-adrenerg.agon./ephedr./
   ther., discont.48 hrs. bef. elect.surg.with gen.anaesthes.& reinstit.  lactat., ren/hepat./thyroid dysfunct., ketoacidos., sev.infect., stress,   pseudoephedr. & common cold preps./ chlorpromaz. & ritodrine,
   not earlier than 48 hrs aft., contin.diet with reg. carbohydr. intake   trauma, uncontr.hyperglycaem., ac.porphyr.  concom.danazol not recomm., act.of anticoag. warfar.) potent.,
   dur.day/energy restrict.diet for overweight pts., reg.diabet.monit.  Side effects: GI disturbs., metall.tast, incr.appet., weight gain,   ciclosporin plasma conc.incr., dysglycaem.risk with fluoroquinolo-
   tests, poss. hypoglycaem. with concom.insulin/sulphonylureas,   hypersens.reacts., bld. dyscras., rash, Stev.Johns.syndr., alcoh.  nes, St John’s Wort decr.expos.
   poss. dos.adjustm.of anticoags., poss.tabs.shells in faeces, annual   induc.flush.
   monit.of Vit B12 & folic acid, dur. longt. ther., condits.caus.dehydrat.,   Special precautions: Reduc.dos.in ren./hepat. dysfunct., infects.,   MENGEN, Novagen [P/S]
   infect./trauma/ low calor.diet, stabilis.pts.on combin.ther.in hosp.  trauma, shock, poss.anaesth., substit.with insul.therapy prior to   Metformin HCl.
   Drug interactions: Intrins.hyperglycaem.activ.of glucocortic./  maj.surg., elderly, debilit., malnour., adren.pituit.insuff., excess.   Indications: Type II diab.mellit.when diet.fail. esp. if pt.overweight.
   beta-2-agon.& diurets., poss. hypoglycaem. with concom.sulpho-  exerc., lact.intol.  admin.alone or as combinat. ther.with a sulphonylurea or insul.
   nylurea, ACE-inhibit. poss.decr.bld.gluc.lev., reduc.clear.with cime-  Warnings: Incr.CV mortality.  (S3) TABS, A40/21.2/0638, 0639, 0640
   tidine, warfar.activ.dimin.  Drug interactions: Rifampic., thiazide diuret., adrenal., chlor-  714680-001: 500 mg, 100, R46,12
   See also MDR page 497.       promazine, corticoster., diazoxide, cyclophosphamide, gemfibro-  714681-001: 850 mg, 60, R50,90
   GLUCOVANCE, (Biopharma Div) Merck [P/S]  zil, isoniazid, OC’s, oestrogens, phenytoin & thyroid horm.dimin.  714683-001: 1000 mg, 60, R59,32
                                                              Dosage: Admin.in div.dos.with meals.
                                effs., chloramphenic., fluconazole, miconazole, salicyl., sulphona-
   Metformin, glibenclamide     mid., azapropazone, phenylbutazone, coumar.anticoags., heparin,   Adults: Init.500 mg 3x/day. Aft.10-15 days adjust dos.or incr.to
   Indications: Init.ther.in type 2 diabet.as adjunct. where diet and   cimetidine, ranitidine, clofibrate, MAOI’s & ß-adrenorecept.block.  850 mg or 1 000 mg 2x/day. Slow. dos. incr.poss.improv.GI toler.
   exerc.alone not achiev.adeq. glycaem. control, 2  line ther.in type   agents incr.hypoglycaem.eff., ethanol may enhanc.act., ß-block.  Caut incr.to max. 3 g/day if contr.incompl. Poss.dos.reduct.once contr.
                       nd
   2 diabet. where diet, exerc.& init.sulphonylurea/metformin treatm.  may mask sympts.  Contraindications: Ketoacidos., diabet.pre-coma/ hist.thereof,
   did not achiev.adeq.glycaem.control.                       imp.ren.funct., pancreatit., chron.liv.dis., hist.of/states assoc.with
   (S3) TABS, 36/21.2/0412, 0413.  GLYGARD, Cipla Medpro [P/S]  lact. acidos. eg.shock/pulm.insuffic., card.fail., recent MI, condits.
   701111-001: 500 mg/2,5 mg, 30, R102,50  Gliclazide.        assoc.with hypox., hepat.insuffic., ac.alcoh.intoxicat., alcohol., safety
   701111-002: 500 mg/2,5 mg, 60, R204,93  Indications: Non-insulin-depend./Type 2 diabet.mellit.where diet.  in pregn.& lactat.not est., safety & effic.not est.in childr.
   701112-001: 500 mg/5 mg, 30, R102,50  managem.alone insuffic.  Side effects: Lact.acidos., megablast.anaem., GI disturbs., metal.
   701112-002: 500 mg/5 mg, 60, R204,93  (S3) TABS, 34/21.2/0070  taste, ketoacidos., ketonur., sev. cholestat.hepatit., hypersens.,
   Dosage: Indiv.init.at low.incr.grad. Admin.bef. meal in 1-2 div.dos   700717-003: 80 mg, 60, R65,85  hypoglycaem.
   in the morn.& even.          Dosage: Admin.30 mins.bef./with meals. Indiv. Init: ½-1 tab.dly.  Special precautions: Assess risk fact.assoc. with lact.acidos.,
   Diet & exerc.alone not adeq: 1 tab of 250/1,25 mg strength dly.  in div.dos.morn.& even.with max. dly. dos. 4 tabs. Aveg.dose: 1 tab   discont.& hospitalis.immed.if metabol. acidos.suspect., determ.
   Inadeq.monother.contr: 1 tab.of 500/2,5 mg strength dly.  2xdly with meals.  ser.creatin.lev. bef. init. ther.& reg.thereaft., monit.ren.funct. reg.
   Substitut.from bi-ther.by metformin with insulin-secreta-  Contraindications: Sulphonylurea hypersens., IDDM, ren./hepat.  esp. elderly, condits.poss.imp.ren.funct., ther. assoc. with incr.CV
   gogue: 1-2 tabs.dly.of 500/2,5 mg strength or 500/5 mg strength   insuff., ketoacidos., adren./ thyroid dysfunct., safety in pregn.& lac-  mort., discont.bef. elect.surg. with gen.anaesthes./clinic.investig.
   adjust. accord.to prev.dos.of each compon.  tat.not est., safety & effic.in paed.not est., unstab.diabet.  involv. iodinat. contrast media & do not resume earlier than 48 hrs.
   Dos.can be adjust.every 1-2 wks.accord.to results. Tot.dly.dos.of   Side effects: Hypoglycaem.reacts., weight chang., skin reacts.,   aft.& ren.funct.eval., contin.diet with reg. carbohydr. intake dur.day/
   4 tabs of 500/5 mg strength not to be exceed.  bld.dyscras., GI disturbs., hypersens.reacts.incl.cholest.jaund.&   energy restrict.diet for overweight pts., reg.diab.monit., poss. hypo-
   Contraindications: Sulphonylurea hypersens., insul.depend.dia-  Stev.-Johns. syndr.  glycaem. with concom.insulin/sulphonylur., avoid alcoh.& alcoh.-
   bet., ketosis/ketoacidos., diabet. pre-coma, ren.dis./dysfunct., ac./  Special precautions: Acidos., sev.burns, coma, maj. surg., trauma/  contain.meds., concom. warfar., not advis.in condits.caus.dehydrat./
   chron.dis.which caus.sev.tiss.hypox., chron.liv.dis., ac.alcohol intoxi-  condits.where bld.gluc.lev.sev. influenc./insul.needs rapid.chang.,   ser. infects./ trauma/low cal.intake, annual Vit.B 12 estimat., stabilis.
   cat., pancreatit., porphyr., concom. miconazole, pregn., lactat., safety   contin.diet restrict., monit.gluc.lev.esp.in elderly & concom. meds.   pts.in hosp.on concom.insulin
   & effic.in childr. not est.  aff.metabol./glycaem.contr.of diab.mellit., ren./hepat.insuff., sul-  Drug interactions: Alcoh.intox.incr.lact.acidos. risk, intrins.hyper-
   Side effects: Lact.acidos., hypoglycaem., GI disturbs., taste dis-  phonamide/thiamine-type meds.cross.sens., assoc.incr.CV mortal.  glycaem.activ.of glucocortic./ beta-2-agon.& diuret., ACE inhibit.
   turbs., decr.vit 12 absorpt., skin & subcutan.tiss.disords., photosens.,   as compar. to diet alone/diet & insulin., sev.diarrh., intest. obstruct.,   decr.bld.gluc., reduc. ren.clear.with cimetidine, warfar.activ. dimin.,
   CNS effs., fev., paraesthes., bld.dyscras., hepatit., trans.vis. disturbs.   prolong. vomit.& gastro paresis.  imp.Vit.B 12 absorpt.with longt.ther.
   at commenc.of ther., porphyr.crises., hyponatraem.  Drug interactions: Coumarin/antifung./barbits./ cimetid./MAOI’s/
   Special precautions: Elderly, assess risk fact. assoc.with lact.  ranitidine/ß-blocks./ cyclophosphamide/ salicylates/hepat.enzyme   METFORAL, AI Pharm Ltd [P/S]
   acidos., assoc.risk of incr. cardiovasc. mortal., monit.ren.funct./  inhibits./tetracyclin./sulphonamid./ phenylbutazone/ halofenate/  Metformin HCl.
   vit 12,lev., surg., adren./pituit.insuffic., concom.ß-block. poss. mask   ketoconazole & clofibrate poss.potent.hypoglycaem.act., oestrog./   Indications: Type II diab.mellit.when diet. & exerc.alone insuffic.or
   hypoglycaem.sympts., consid.substit. insul.ther.in surg.intervent./  corticoster. /thiaz.diuret.& adrenal.may dimin.act., hypoglycaem.   in case of obesity, combinat.ther.with sulphonylurea.
   other cases of diab. decompensat., discont.prior to admin.iodinat.   poss.mask.by ß-blocks.  (S3) TABS, 34/21.2/0359, 0360
   contrast media & re-instate only aft.ren.funct. determ. as norm.,   702385-001: 500 mg, 100, R51,31
   disulfiram-like react.with alcohol, poss.cross reactiv.to sulphona-  GLYTAB, Forrester [P/S]  702363-001: 850 mg, 60, R55,27
   mides & derivat.             Gliclazide.                   Dosage: Admin.in div.dos.with meals. Use in childr.und.12 yrs.
   Drug interactions: Phenylbutazone incr. hypoglycaem. eff., half-  Indications: Type 2 diabet.with diet.meas./ lifestyle chang.& exerc.,   not recomm.
   life of glibenclam.incr. with fluconazole, hypoglycaem.report.with   when diet.meas./ lifestyle & exerc.alone insuffic.  Adults: Init.850 mg 2x/day or 500 mg 3x.day with/aft.food.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page328.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page324.html">324</a>&nbsp;&nbsp;&nbsp;<a href="page325.html">325</a>&nbsp;&nbsp;&nbsp;<a href="page326.html">326</a>&nbsp;&nbsp;&nbsp;<a href="page327.html">327</a>&nbsp;&nbsp;&nbsp;<a href="page328.html">328</a>&nbsp;&nbsp;&nbsp;<a href="page329.html">329</a>&nbsp;&nbsp;&nbsp;<a href="page330.html">330</a>&nbsp;&nbsp;&nbsp;<a href="page331.html">331</a>&nbsp;&nbsp;&nbsp;<a href="page332.html">332</a>&nbsp;&nbsp;&nbsp;<a href="page333.html">333</a>&nbsp;&nbsp;&nbsp;<a href="page334.html">334</a>
             </td>
             <td width="35%"><a href="page330.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page330.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
